Cargando…
Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862173/ https://www.ncbi.nlm.nih.gov/pubmed/27160192 http://dx.doi.org/10.1186/s12977-016-0264-y |
| _version_ | 1782431321735299072 |
|---|---|
| author | Loret, Erwann P. Darque, Albert Jouve, Elisabeth Loret, Elvenn A. Nicolino-Brunet, Corinne Morange, Sophie Castanier, Elisabeth Casanova, Josiane Caloustian, Christine Bornet, Charléric Coussirou, Julie Boussetta, Jihen Couallier, Vincent Blin, Olivier Dussol, Bertrand Ravaux, Isabelle |
| author_facet | Loret, Erwann P. Darque, Albert Jouve, Elisabeth Loret, Elvenn A. Nicolino-Brunet, Corinne Morange, Sophie Castanier, Elisabeth Casanova, Josiane Caloustian, Christine Bornet, Charléric Coussirou, Julie Boussetta, Jihen Couallier, Vincent Blin, Olivier Dussol, Bertrand Ravaux, Isabelle |
| author_sort | Loret, Erwann P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4862173 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-48621732016-05-11 Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial Loret, Erwann P. Darque, Albert Jouve, Elisabeth Loret, Elvenn A. Nicolino-Brunet, Corinne Morange, Sophie Castanier, Elisabeth Casanova, Josiane Caloustian, Christine Bornet, Charléric Coussirou, Julie Boussetta, Jihen Couallier, Vincent Blin, Olivier Dussol, Bertrand Ravaux, Isabelle Retrovirology Erratum BioMed Central 2016-05-09 /pmc/articles/PMC4862173/ /pubmed/27160192 http://dx.doi.org/10.1186/s12977-016-0264-y Text en © Loret et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Erratum Loret, Erwann P. Darque, Albert Jouve, Elisabeth Loret, Elvenn A. Nicolino-Brunet, Corinne Morange, Sophie Castanier, Elisabeth Casanova, Josiane Caloustian, Christine Bornet, Charléric Coussirou, Julie Boussetta, Jihen Couallier, Vincent Blin, Olivier Dussol, Bertrand Ravaux, Isabelle Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial |
| title | Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial |
| title_full | Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial |
| title_fullStr | Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial |
| title_full_unstemmed | Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial |
| title_short | Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial |
| title_sort | erratum to: intradermal injection of a tat oyi-based therapeutic hiv vaccine reduces of 1.5 log copies/ml the hiv rna rebound median and no hiv dna rebound following cart interruption in a phase i/ii randomized controlled clinical trial |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862173/ https://www.ncbi.nlm.nih.gov/pubmed/27160192 http://dx.doi.org/10.1186/s12977-016-0264-y |
| work_keys_str_mv | AT loreterwannp erratumtointradermalinjectionofatatoyibasedtherapeutichivvaccinereducesof15logcopiesmlthehivrnareboundmedianandnohivdnareboundfollowingcartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT darquealbert erratumtointradermalinjectionofatatoyibasedtherapeutichivvaccinereducesof15logcopiesmlthehivrnareboundmedianandnohivdnareboundfollowingcartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT jouveelisabeth erratumtointradermalinjectionofatatoyibasedtherapeutichivvaccinereducesof15logcopiesmlthehivrnareboundmedianandnohivdnareboundfollowingcartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT loretelvenna erratumtointradermalinjectionofatatoyibasedtherapeutichivvaccinereducesof15logcopiesmlthehivrnareboundmedianandnohivdnareboundfollowingcartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT nicolinobrunetcorinne erratumtointradermalinjectionofatatoyibasedtherapeutichivvaccinereducesof15logcopiesmlthehivrnareboundmedianandnohivdnareboundfollowingcartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT morangesophie erratumtointradermalinjectionofatatoyibasedtherapeutichivvaccinereducesof15logcopiesmlthehivrnareboundmedianandnohivdnareboundfollowingcartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT castanierelisabeth erratumtointradermalinjectionofatatoyibasedtherapeutichivvaccinereducesof15logcopiesmlthehivrnareboundmedianandnohivdnareboundfollowingcartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT casanovajosiane erratumtointradermalinjectionofatatoyibasedtherapeutichivvaccinereducesof15logcopiesmlthehivrnareboundmedianandnohivdnareboundfollowingcartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT caloustianchristine erratumtointradermalinjectionofatatoyibasedtherapeutichivvaccinereducesof15logcopiesmlthehivrnareboundmedianandnohivdnareboundfollowingcartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT bornetcharleric erratumtointradermalinjectionofatatoyibasedtherapeutichivvaccinereducesof15logcopiesmlthehivrnareboundmedianandnohivdnareboundfollowingcartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT coussiroujulie erratumtointradermalinjectionofatatoyibasedtherapeutichivvaccinereducesof15logcopiesmlthehivrnareboundmedianandnohivdnareboundfollowingcartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT boussettajihen erratumtointradermalinjectionofatatoyibasedtherapeutichivvaccinereducesof15logcopiesmlthehivrnareboundmedianandnohivdnareboundfollowingcartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT coualliervincent erratumtointradermalinjectionofatatoyibasedtherapeutichivvaccinereducesof15logcopiesmlthehivrnareboundmedianandnohivdnareboundfollowingcartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT blinolivier erratumtointradermalinjectionofatatoyibasedtherapeutichivvaccinereducesof15logcopiesmlthehivrnareboundmedianandnohivdnareboundfollowingcartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT dussolbertrand erratumtointradermalinjectionofatatoyibasedtherapeutichivvaccinereducesof15logcopiesmlthehivrnareboundmedianandnohivdnareboundfollowingcartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial AT ravauxisabelle erratumtointradermalinjectionofatatoyibasedtherapeutichivvaccinereducesof15logcopiesmlthehivrnareboundmedianandnohivdnareboundfollowingcartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial |